Primary prevention of cardiovascular disease endpoints using beta-blockers.
Michalewicz
L
L
Chambers
R
R
Grodzicki
T
T
Michalewiz
L
L
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use*; D000959:Antihypertensive Agents / Q000627:therapeutic use*; D002318:Cardiovascular Diseases / Q000517:prevention & control*; D006801:Humans
D000319:Adrenergic beta-Antagonists; D000959:Antihypertensive Agents